Drugs / KSD-201
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06708936 | Mar 2026 | clear cell renal carcinoma | Kousai Bio Co., Ltd. | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KSD-201 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06708936 ↗ |
| Route | Subcutaneous | “KSD-201 route of administration: subcutaneous injection.” NCT06708936 ↗ |